Variant report
Variant | esv3410463 |
---|---|
Chromosome Location | chr21:17564033-17564502 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs114376526 | chr21:17564092-17564093 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147967984 | chr21:17564101-17564102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570933057 | chr21:17564152-17564153 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529358765 | chr21:17564157-17564158 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527317453 | chr21:17564186-17564187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547454702 | chr21:17564213-17564214 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192060968 | chr21:17564236-17564237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549414460 | chr21:17564256-17564257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs535996675 | chr21:17564266-17564267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs184408108 | chr21:17564280-17564281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569536732 | chr21:17564413-17564414 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190481658 | chr21:17564414-17564415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs238954 | chr21:17564415-17564416 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs139232387 | chr21:17564419-17564420 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375047516 | chr21:17564442-17564443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182215841 | chr21:17564453-17564454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs2823633 | chr21:17564475-17564476 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs184397734 | chr21:17564486-17564487 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Alzheimer''s disease | 18923514 | CNVD |
Alzheimer''s disease | 20877625 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Alzheimer''s disease | 21956041 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Epilepsy | 20502679 | CNVD |
22q11.2 microdeletion syndrome | 19750312 | CNVD |
Breast cancer | 20409316 | CNVD |
Gastric cancer | 18160780 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:17553400-17566400 | Weak transcription | Fetal Stomach | stomach |
2 | chr21:17558400-17566400 | Weak transcription | Brain Anterior Caudate | brain |
3 | chr21:17559000-17571200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr21:17559600-17566200 | Weak transcription | Ovary | ovary |
5 | chr21:17559600-17566600 | Weak transcription | Placenta | Placenta |
6 | chr21:17563000-17565400 | Weak transcription | NHDF-Ad | bronchial |
7 | chr21:17563400-17565200 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr21:17563600-17567200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |